Early detection through these simple tests can go a long way in preventing chronic kidney disease and the need for dialysis ...

Expert discusses how, despite its importance, albuminuria screening remains underutilized, and improving adherence to dual ...

A new, inexpensive urine test that measures two sugar alcohols, sorbitol and xylitol, is making it easier, faster, and far ...

Conversely, patients with low risk for graft failure can be discharged from the care of their transplant nephrologist and ...

Dr. Christopher Kelly: A biomarker is a biological substance that can be objectively measured and tracked to provide ...

A ‘Medical Kundli’ is not a superstition; it is a health blueprint, a complete picture of each partner’s physical, emotional, hormonal, and reproductive well-being ...

A man in his 40s of Middle Eastern descent, with no prior medical history, presented with severe abdominal pain that had ...

Introduction European valvular heart disease guidelines define women as a ‘special group’. To explore what factors have led ...

Rilparencel, a percutaneous minimally invasive injectable product prepared from patients’ own kidney cells, is being developed to treat those with stage 3b or 4 CKD and either type 1 or type 2 ...

Povetacicept is an investigational dual BAFF and APRIL inhibitor being tested for various glomerulonephritis types in clinical trials.

Experts say we’re in a golden age for treating chronic kidney disease, with new drugs like Ozempic yielding major results.

Cardiologist Prof. Dr A.F. Khabir Uddin Ahmed warns that looking fit does not always mean being heart-healthy.